Does TAVR using current-generation devices provide comparable outcomes in patients with bicuspid aortic valve disease compared to those with tricuspid aortic valve disease?
TAVR with newer-generation devices is a viable treatment option for patients with bicuspid aortic valve disease, demonstrating comparable 1-year outcomes to those with tricuspid anatomy.
Using current-generation devices, procedural, postprocedural, and 1-year outcomes were comparable following TAVR for bicuspid AV versus tricuspid AV disease. With newer-generation devices, TAVR is a viable treatment option for patients with bicuspid AV disease.
Halim et al. (Wed,) studied this question.